RhumbLine Advisers’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-58,098
| Closed | -$339K | – | 4313 |
|
|
2025
Q1 | $339K | Sell |
58,098
-6,241
| -10% | -$32.9K | ﹤0.01% | 2821 |
|
|
2024
Q4 | $239K | Buy |
64,339
+651
| +1% | +$3K | ﹤0.01% | 3105 |
|
|
2024
Q3 | $356K | Buy |
63,688
+4,693
| +8% | +$32.8K | ﹤0.01% | 2931 |
|
|
2024
Q2 | $497K | Buy |
58,995
+2,836
| +5% | +$30.2K | ﹤0.01% | 2687 |
|
|
2024
Q1 | $811K | Buy |
56,159
+1,229
| +2% | +$20.3K | ﹤0.01% | 2371 |
|
|
2023
Q4 | $1.18M | Sell |
54,930
-146
| -0.3% | -$2.6K | ﹤0.01% | 2166 |
|
|
2023
Q3 | $1.06M | Buy |
55,076
+237
| +0.4% | +$5.05K | ﹤0.01% | 2173 |
|
|
2023
Q2 | $1.39M | Buy |
54,839
+7,759
| +16% | +$224K | ﹤0.01% | 2116 |
|
|
2023
Q1 | $1.7M | Buy |
47,080
+744
| +2% | +$26.1K | ﹤0.01% | 1888 |
|
|
2022
Q4 | $1.83M | Buy |
46,336
+1,558
| +3% | +$64.8K | ﹤0.01% | 1827 |
|
|
2022
Q3 | $2.09M | Buy |
44,778
+3,335
| +8% | +$155K | ﹤0.01% | 1735 |
|
|
2022
Q2 | $1.82M | Buy |
41,443
+5,307
| +15% | +$292K | ﹤0.01% | 1812 |
|
|
2022
Q1 | $2.61M | Buy |
36,136
+210
| +0.6% | +$15.1K | ﹤0.01% | 1676 |
|
|
2021
Q4 | $2.91M | Sell |
35,926
-676
| -2% | -$67.7K | ﹤0.01% | 1690 |
|
|
2021
Q3 | $4.26M | Buy |
36,602
+616
| +2% | +$80.6K | 0.01% | 1448 |
|
|
2021
Q2 | $5.97M | Sell |
35,986
-1,567
| -4% | -$245K | 0.01% | 1333 |
|
|
2021
Q1 | $5.24M | Sell |
37,553
-4,891
| -12% | -$798K | 0.01% | 1385 |
|
|
2020
Q4 | $7.35M | Buy |
42,444
+1,410
| +3% | +$228K | 0.01% | 1119 |
|
|
2020
Q3 | $5.72M | Sell |
41,034
-11,242
| -22% | -$1.5M | 0.01% | 1076 |
|
|
2020
Q2 | $6.25M | Buy |
52,276
+8,819
| +20% | +$1.05M | 0.01% | 1065 |
|
|
2020
Q1 | $4.34M | Buy |
43,457
+570
| +1% | +$68.6K | 0.01% | 1112 |
|
|
2019
Q4 | $5.04M | Buy |
42,887
+2,215
| +5% | +$219K | 0.01% | 1247 |
|
|
2019
Q3 | $3.5M | Sell |
40,672
-346
| -0.8% | -$26.2K | 0.01% | 1396 |
|
|
2019
Q2 | $2.66M | Buy |
41,018
+2,894
| +8% | +$180K | 0.01% | 1567 |
|
|
2019
Q1 | $2.38M | Sell |
38,124
-934
| -2% | -$43.9K | ﹤0.01% | 1613 |
|
|
2018
Q4 | $1.52M | Buy |
39,058
+12,301
| +46% | +$547K | ﹤0.01% | 1816 |
|
|
2018
Q3 | $1.52M | Sell |
26,757
-1,768
| -6% | -$111K | ﹤0.01% | 1804 |
|
|
2018
Q2 | $2.28M | Buy |
28,525
+856
| +3% | +$71K | ﹤0.01% | 1610 |
|
|
2018
Q1 | $2.4M | Sell |
27,669
-415
| -1% | -$33.5K | 0.01% | 1500 |
|
|
2017
Q4 | $1.94M | Sell |
28,084
-5,151
| -15% | -$412K | ﹤0.01% | 1637 |
|
|
2017
Q3 | $3.02M | Buy |
33,235
+1,744
| +6% | +$149K | 0.01% | 1343 |
|
|
2017
Q2 | $2.34M | Buy |
31,491
+3,152
| +11% | +$253K | 0.01% | 1481 |
|
|
2017
Q1 | $2.65M | Buy |
28,339
+1,100
| +4% | +$99.6K | 0.01% | 1387 |
|
|
2016
Q4 | $1.98M | Buy |
27,239
+1,560
| +6% | +$134K | 0.01% | 1460 |
|
|
2016
Q3 | $2.68M | Buy |
25,679
+2,530
| +11% | +$228K | 0.01% | 1226 |
|
|
2016
Q2 | $1.71M | Buy |
23,149
+6,244
| +37% | +$424K | 0.01% | 1448 |
|
|
2016
Q1 | $951K | Buy |
16,905
+690
| +4% | +$40.7K | ﹤0.01% | 1829 |
|
|
2015
Q4 | $1.09M | Buy |
16,215
+2,020
| +14% | +$108K | ﹤0.01% | 1748 |
|
|
2015
Q3 | $659K | Buy |
14,195
+1,420
| +11% | +$68.8K | ﹤0.01% | 2052 |
|
|
2015
Q2 | $687K | Buy |
12,775
+7,055
| +123% | +$359K | ﹤0.01% | 2121 |
|
|
2015
Q1 | $274K | Buy |
+5,720
| New | +$248K | ﹤0.01% | 2664 |
|
Other funds holding NVRO
RhumbLine Advisers's NVRO Position: Q2 2025 in Review
RhumbLine Advisers sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 58,098 shares — an estimated $339K sold.
RhumbLine Advisers first reported a position in NVRO in Q1 2015 and held it in 41 quarters. The position peaked at $7.35M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- RhumbLine Advisers reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- RhumbLine Advisers sold 58,098 NEVRO CORP. shares in Q2 2025, an estimated $339K.
- RhumbLine Advisers first reported a position in NEVRO CORP. in Q1 2015 and held it in 41 quarters.
- RhumbLine Advisers's NEVRO CORP. position peaked at $7.35M in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.